Concord Drugs Limited: Detailed financials

Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.

Company financials

Particulars	Jun-24	Sep-24	Dec-24	Mar-25	Jun-25	Dec-25	Mar-26	Jun-26
	12	12	11	10	14	17	38	21
	—	0.01	—	—	—	0.02	0.01	0.01
	12	12	10	10	13	17	37	19
	9	12	7	9	11	14	35	17
	0.35	−2	1	−0.74	0.61	0.01	−0.95	0.39
	1	0.93	1	1	0.89	1	2	1
	0.45	0.47	0.50	0.61	0.49	0.34	0.40	0.40
	0.34	0.34	0.37	0.38	0.37	0.31	0.35	0.35
	0.38	0.41	0.25	0.21	0.29	0.42	0.53	0.49
	0.83	0.88	1	1	1	0.95	2	2
	0.49	0.54	1	0.67	0.65	0.64	1	2
	0.04	0.07	0.53	0.06	0.16	0.30	0.75	2
	0.01	0.02	0.30	0.02	0.04	0.08	0.22	0.43
	0.03	0.04	0.23	0.04	0.12	0.22	0.53	1
Financial ratios
	7.10%	7.12%	12.96%	10.11%	7.49%	5.60%	3.96%	10.94%
	0.26%	0.32%	2.13%	0.38%	0.88%	1.30%	1.40%	5.30%
	0.03	0.04	0.23	0.04	0.12	0.16	0.47	0.85

Revenue

₹ crore

Select any table row to compare its reported history.

Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.